A crosstalk between TGF-β/Smad3 and Wnt/β-catenin pathways promotes vascular smooth muscle cell proliferation
- 1 May 2016
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 28 (5) , 498-505
Abstract
No abstract availableKeywords
Funding Information
- National Heart Lung and Blood Institute R01 (HL-068673)
- D DiRenzo and M Chaudhary (HL-110853)
- Wisconsin Partnership Program New Investigator Award (ID2832)
This publication has 43 references indexed in Scilit:
- Aberrant activation of Wnt/β-catenin signaling drives proliferation of bone sarcoma cellsOncotarget, 2015
- Serum and glucocorticoid-regulated kinase 1 promotes vascular smooth muscle cell proliferation via regulation of β-catenin dynamicsCellular Signalling, 2014
- Wnt5a-Induced Wnt1-Inducible Secreted Protein-1 Suppresses Vascular Smooth Muscle Cell Apoptosis Induced by Oxidative StressArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- Inhibition of Wnt/β-catenin pathway by niclosamide: A therapeutic target for ovarian cancerGynecologic Oncology, 2014
- Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosisNature Communications, 2012
- Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin PathwayPLOS ONE, 2011
- Wnt11 in 2011 – the regulation and function of a non‐canonical WntActa Physiologica, 2011
- Noncanonical Wnt11 Inhibits Hepatocellular Carcinoma Cell Proliferation and MigrationMolecular Cancer Research, 2010
- TGF-β through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes.Journal of Clinical Investigation, 1994